13G Filing: Brookside Capital and Immune Design Corp. (IMDZ)

Page 5 of 7 – SEC Filing

(f)
?
An employee benefit plan or endowment fund in accordance with
240.13d-1(b)(1)(ii)(F);(g)
?
A parent holding company or control person in accordance with
240.13d-1(b)(1)(ii)(G);(h)
?
A savings associations as defined in Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813);(i)
?
A church plan that is excluded from the definition of an investment
company under section 3(c)(14) of the Investment Company Act
of 1940 (15 U.S.C. 80a-3);(j)
?
Group, in accordance with 240.13d-1(b)(1)(ii)(J).[x] If this statement is filed pursuant to 240.13d-1(c), check this box.
Item 4. Ownership.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer
identified in Item 1.(a)

Amount beneficially owned: 1,299,013.(b)

Percent of class: 5.07% based upon 25,619,732 shares
of Common Stock outstanding.(c)

Number of shares as to which the person has: 1,299,013.(i)
Sole power to vote or to direct the vote: 1,299,013.(ii)
Shared power to vote or to direct the vote: 0.

Follow Immune Design Corp. (NASDAQ:IMDZ)